British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025

The overall objective of this living guideline with a fixed-interval schedule is to provide up-to-date, evidence-based recommendations for the management of Behçets disease/syndrome in adults, children and young people. The literature will be reviewed at least every 6 months, with a living guideline updating cycle of 12 months. The current iteration aims to: (i) offer an appraisal of all relevant literature up to 23 May 2025 focusing on any key developments; (ii) address important, practical clinical questions relating to the primary guideline objective; and (iii) provide guideline recommendations and appropriate research recommendations.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2025-09-29
DOI
https://doi.org/10.1093/bjd/ljaf383
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025

Christina Wlodek, Aykut Ferhat Çelık, Mark Clement-Jones, Maria Hashme et al.
British Journal of Dermatology
Ocular Diseases and Behçet’s Syndrome
article

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025

Christina Wlodek, Aykut Ferhat Çelık, Mark Clement-Jones, Maria Hashme, Gülen Hatemi, Ana Poveda‐Gallego, Ali Jawad, Paul A. Brogan, Harry Petrushkin, Steve Higgins, Jane Setterfield, Ruth Murphy, Laura Forrest, Clare Pain, Robert J. Moots, Poonam Sharma, Alina M Constantin, Richard West, Seema Kalra, Hilary McKee
article en

Abstract

The overall objective of this living guideline with a fixed-interval schedule is to provide up-to-date, evidence-based recommendations for the management of Behçets disease/syndrome in adults, children and young people. The literature will be reviewed at least every 6 months, with a living guideline updating cycle of 12 months. The current iteration aims to: (i) offer an appraisal of all relevant literature up to 23 May 2025 focusing on any key developments; (ii) address important, practical clinical questions relating to the primary guideline objective; and (iii) provide guideline recommendations and appropriate research recommendations.

British Journal of DermatologyVol. 194(1)
Moorfields Eye Hospital NHS Foundation Trust (GB), University of Liverpool (GB), Edge Hill University (GB), King's College London (GB), Barts Health NHS Trust (GB), Aintree University Hospitals NHS Foundation Trust (GB), Queen Elizabeth Hospital Birmingham (GB), University Hospitals of North Midlands NHS Trust (GB), Great Ormond Street Hospital (GB), Peterborough City Hospital (GB), Northern Health and Social Care Trust (GB), Alder Hey Children's NHS Foundation Trust (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), Istanbul University-Cerrahpaşa (TR), British Association of Dermatologists (GB), Office of Patient Care Services (US), Moorfields Eye Hospital (GB), St. James's Hospital (IE), Liverpool Womens NHS Foundation Trust (GB), University College London (GB), University of Birmingham (GB)
Amgen, Pfizer, Celltrion, British Association of Dermatologists, British Society for Rheumatology, LEO Pharma, UCB Pharma
Openalex Percentile: Top 61%
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.